The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults
In this file photo taken on August 05, 2021, vials and syringes of the Johnson and Johnson Janssen Covid-19 vaccine are displayed for a photograph at a Culver City Fire Department vaccination clinic in Culver City, California. (Photo: AFP)
New Delhi: An expert panel of central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on Sunday.
The Drugs Controller General Of India has already approved Covovax for restricted use in emergency situations in adults on December 28.
It is yet to be included in the country’s inoculation programme.
Next Story
